Your browser doesn't support javascript.
POINT: Should Therapeutic Heparin Be Administered to Acutely Ill Hospitalized Patients With COVID-19? Yes.
Tritschler, Tobias; Le Gal, Grégoire; Brosnahan, Shari; Carrier, Marc.
  • Tritschler T; Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Electronic address: tobias.tritschler@insel.ch.
  • Le Gal G; Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.
  • Brosnahan S; Division of Pulmonary, Critical Care, and Sleep Medicine, New York University Langone Health System, New York, NY.
  • Carrier M; Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.
Chest ; 161(6): 1446-1448, 2022 06.
Article in English | MEDLINE | ID: covidwho-1739605
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Heparin / COVID-19 Limits: Humans Language: English Journal: Chest Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Heparin / COVID-19 Limits: Humans Language: English Journal: Chest Year: 2022 Document Type: Article